Freeman, C. L., Larson, S., Nadeem, O., Munshi, N., Iida, S., Mailankody, S., Neri, P., Gregory, T., Piasecki, J., Ziyad, S., Hu, H., Groeneveld, S. J., Johnston, S., Pulham, T., Wong, S., Davis, J., Bal, S., Kumar, A., Patel, K. (2025). Trial in progress: QUINTESSENTIAL—a phase 2 study of arlocabtagene autoleucel (arlo-cel) in patients with relapsed/refractory multiple myeloma (RRMM). Blood. https://doi.org/10.1182/blood-2025-4079